AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 233.41 |
Market Cap | 68.39B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 5.86 |
PE Ratio (ttm) | 40.24 |
Forward PE | n/a |
Analyst | Buy |
Ask | 239.16 |
Volume | 1,822,449 |
Avg. Volume (20D) | 1,816,927 |
Open | 236.50 |
Previous Close | 236.19 |
Day's Range | 233.01 - 237.40 |
52-Week Range | 218.75 - 248.42 |
Beta | undefined |
About BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and pr...
Analyst Forecast
According to 6 analyst ratings, the average rating for BDX stock is "Buy." The 12-month stock price forecast is $275, which is an increase of 16.61% from the latest price.
Next Earnings Release
Analysts project revenue of $5.12B, reflecting a 8.80% YoY growth and earnings per share of 2.99, making a 11.57% increase YoY.
1 month ago · investopedia.com
These 5 Stocks Have 50 Years of Dividend Growth—Here's How to Find MoreWith a new presidential administration set to take office on Jan. 20, 2025, some investors may be uncertain about how new policies and personnel will affect the stock market and interest rates. Will t...